Prostamax
Prostate gland bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, swelling, or itching at the injection site may occur. Typically resolves within 1-2 hours. Rotate injection sites to minimize recurrence. Apply ice if swelling persists.
Anaphylaxis or severe allergic response is rare but possible with any peptide. Symptoms include difficulty breathing, facial swelling, or severe rash. Seek immediate medical attention if these occur. Individuals with known peptide allergies should avoid use.
Transient headache may occur within hours of injection. Typically self-resolving. Ensure adequate hydration and rest. If persistent, discontinue and consult a healthcare provider.
Mild nausea or stomach discomfort may occur, particularly if injected on an empty stomach. Eating a light meal before injection may help. Symptoms typically resolve within a few hours.
Repeated injections at the same site can cause localized fat loss (lipoatrophy) or fat thickening (lipohypertrophy). Prevent by rotating injection sites systematically. If lipodystrophy develops, avoid injecting in that area for several months.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mcg |
| Frequency | 1x daily |
| Timing | Morning, sublingual or subcutaneous |
| Route | Subcutaneous |
Khavinson bioregulator peptide. Limited Western clinical trials; widely used in Russia and Eastern Europe. Start at lower end (10 mcg) and assess response over 4-6 weeks before adjusting. For research purposes only.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
Prostamax is a short peptide bioregulator (2-4 amino acids) derived from prostate tissue that is proposed to regulate gene expression and support normal prostate gland function through tissue-specific signaling. The peptide is theorized to interact with cellular receptors and transcription factors to promote healthy prostate tissue homeostasis and normal urinary function. Research on Khavinson bioregulators suggests they may modulate inflammatory pathways and support organ-specific regenerative processes, though the precise molecular mechanism in human prostate tissue remains incompletely characterized.
Tissue-Specific Gene Regulation
Bioregulator peptides are proposed to bind to specific cellular receptors in prostate tissue and influence transcription factor activity, thereby modulating expression of genes involved in prostate cell differentiation and function.
Inflammatory Modulation
Khavinson peptides may influence inflammatory signaling pathways in prostate tissue, potentially supporting normal inflammatory responses and tissue homeostasis.
Cellular Differentiation and Proliferation
Short peptide bioregulators are theorized to support normal cellular differentiation patterns in prostate epithelial cells and regulate cell cycle progression.
- Prostamax is part of the Khavinson bioregulator series, a class of short peptides derived from animal organ tissues
- Bioregulator peptides are proposed to work through tissue-specific mechanisms rather than systemic hormonal pathways
- Clinical evidence in Western literature is limited; most research and clinical use is documented in Russian and Eastern European medical literature
- The exact amino acid sequence and molecular targets of Prostamax are not publicly disclosed in peer-reviewed literature
Track your Prostamax research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Prostamax is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.